Arak, H. and Kuş, T. (2024) “Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy”, European Journal of Therapeutics. doi: 10.58600/eurjther2151.